Clinical Trials · NCT00630799
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- GP-Pharm
- Enrollment
- 20
- Start date
- May 2008
- Locations
- 8 sites, United States
- Primary endpoint
- Percent of successful patients achieving chemical castration